Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Bioequivalence of Albuterol Sulfate Inhalation Aerosol in Stable Mild Asthma
NCT05292976Phase 3Withdrawn
- Sponsor
- Aurobindo Pharma Limited
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol in asthma, sponsored by Aurobindo Pharma Limited. Planned start Apr 2022; status: withdrawn.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05292976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05292976.